Abstract
Objective: Currently, use of adjuvant radiation (RT) via brachytherapy or pelvic RT is recommended for patients with surgically staged, low-risk stage II disease with the option of adding chemotherapy (CT) for high-risk disease. However, these recommendations are based on small numbers of stage II EC patients within larger randomized clinical trials or small retrospective reviews. The purpose of this study was to explore patterns of adjuvant therapy and outcomes in a large retrospective cohort of stage II EC patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
